CLINICAL_TRIALS
research
· 2025-03-14
Clinical Trial Update: Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain [Phase 3]
Summary
A Phase 3 clinical trial evaluating Praga Formulation for neuropathic pain is currently recruiting. The study, sponsored by EMS, aims to assess the formulation'…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMS | Conditions: Neuropathic Pain | Phase 3 | Status: RECRUITING